Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

p53 and ANXA4/NF‑κB p50 complexes regulate cell proliferation, apoptosis and tumor progression in ovarian clear cell carcinoma.

International journal of molecular medicine - 1 Dec 2020

Liu Juanjuan, Wang Huimin, Zheng Mingjun, Deng Lu, Zhang Xue, Lin Bei

Abstract excerpt

Annexin IV (ANXA4) is highly expressed in ovarian clear cell carcinoma (OCCC); however, its underlying molecular mechanism in OCCC remains unknown. The present study aimed to identify the molecule that ANXA4 may act on and to determine its underlying molecular mechanism. Immunohistochemistry, co‑immunoprecipitation and western blotting were performed to detect the expression and interaction of ANXA4, and its...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Nucleus
Share to Disease Progression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to NF-kappa B p50 Subunit

Share to Ovarian Neoplasms

Share to Proportional Hazards Models

Share to Protein Interaction Maps

Share to Tumor Suppressor Protein p53

Source

Open in PubMed Open full text

Identifiers

PMID: 33125094
DOI: 10.3892/ijmm.2020.4757
PMCID: PMC7595666

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

p53 and ANXA4/NF‑κB p50 complexes regulate cell proliferation, apoptosis and tumor progression in ovarian clear cell carcinoma.PMID 33125094Read ↗

Current Position of the Molecular Therapeutic Targets for Ovarian Clear Cell Carcinoma: A Literature ReviewSemantic proximity Read ↗

Evaluation of Annexins Family as Potential Biomarker for Predicting Progression and Prognosis in Clear Renal Cell CarcinomaSemantic proximity Read ↗

Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of AnnexinsSemantic proximity Read ↗

Ovarian clear cell adenocarcinoma: a continuing enigma.Semantic proximity Read ↗

Annexin A11(ANXA 11) facilitates oral squamous cell carcinoma progression via activating the PI3K/AKT signaling pathwaySemantic proximity Read ↗

ANXA4 Activates JAK-STAT3 Signaling by Interacting with ANXA1 in Basal-Like Breast CancerSemantic proximity Read ↗

Association of annexin A2 with cancer development (Review)Semantic proximity Read ↗

The Potential Role of Complement System in the Progression of Ovarian Clear Cell Carcinoma Inferred from the Gene Ontology-Based Immunofunctionome AnalysisSemantic proximity Read ↗

Annexin A3 and cancer (Review)Semantic proximity Read ↗

Promoter Methylation status of HIN-1 associated with outcomes of ovarian clear cell adenocarcinomaSemantic proximity Read ↗

Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma.Semantic proximity Read ↗

Osteopontin-c Splicing Isoform Contributes to Ovarian Cancer ProgressionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.